Oral selective estrogen receptor degraders (Serds) as a novel breast cancer therapy: Present and future from a clinical perspective

1. Hernando, C.
2. Ortega-Morillo, B.
3. Tapia, M.
4. Moragón, S.
5. Martínez, M.T.
6. Eroles, P.
7. Garrido-Cano, I.
8. Adam-Artigues, A.
9. Lluch, A.
10. Bermejo, B.
11. Cejalvo, J.M.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.3390/IJMS22157812 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus